Moleculin Biotech, Inc. (MBRX) stock is rising today: What’s Going on?
Moleculin Biotech, Inc. (MBRX) announced today that it has been granted Rare Pediatric Disease Designation (RPD) for WP1066 to treat ependymoma after which the MBRX stock price saw an uptrend of 7.18% to reach $4.16 a share at the time of this writing. MBRX stock was also green in the previous trading session and went […]
A Bet That Definitely Worked; But Persistence Needed: Moleculin Biotech Inc. (MBRX)
Moleculin Biotech, Inc., (Nasdaq: MBRX) shares are trade -2.84% to $4.78. Based on the relationship between its 200-day and 20-day major moving averages, Moleculin Biotech Inc. (MBRX) has been in rally mode. MBRX shares have risen 4.72% in the past 30 days. Stocks have declined -7.98% over the trailing 12 months, outperforming the market by […]
